Chief Executive Officer
Envol Biomedical
New York, New York
Jake McDonald is the CEO of Envol Biomedical, and has over 25 years of experience in Toxicology/PK and drug development.
C. Edwin Garner, Ph.D., the founder of Mammoth Preclinical Consulting, has diverse cross functional experience from over 25 years in large pharma, start ups, and basic research in xenobiotic metabolism and pharmacokinetics. Dr Garner is an expert in pharmacokinetic and PBPK modeling/simulation based translation of preclinical PK and PD to clinical environment. He has contributed to discovery and development in numerous therapeutic areas in small and large molecule space including nanoparticulates, antibodies, prodrugs, protein-oligonucleotide constructs, oligonucleotides and gene therapies. He provides support in the planning, executing, and analyzing in vitro and in vivo nonclinical studies in preclinical PBPK/ADME, toxicology and pharmacology disciplines via domestic and international outsourcing. He has provided strategic planning, execution, direction of drug discovery and development programs from lead optimization, through nonclinical IND enabling studies and Phase 1/2. Dr Garner is the author of >100 peer reviewed publications and abstracts. He has contributed to multiple PINDs and INDs, and had direct interaction with regulatory agencies.
Disclosure information not submitted.
Tuesday, October 22, 2024
2:00 PM – 3:00 PM MT